SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending as the community celebrates new all-time highs and anticipates an upcoming listing on Bifinance. Airdrop events and buy contests are generating excitement, with holders emphasizing the coin's resilience and strong community over its nine-month journey on Solana. The focus remains on long-term growth and proving the project's staying power in the meme coin space.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as the top memecoin on Bitcoin, distinguished by its fair launch and strong community backing. With a focus on decentralization and a fixed supply, the community emphasizes its potential for significant growth within the Bitcoin ecosystem. Discussions highlight its unique position as a Bitcoin-native meme coin, contrasting it with Ethereum and Solana-based alternatives.

DMTC or DIAMOND The Cat Coin is a viral meme coin on Solana Blockchain, Based in Thailand and Global and Based on a true story about my lovely cat(DIAMOND) and made by love, I just want my cat to be immortal in this whole world until I die that's a first idea of this project start. We're start from $2,000 Market cap and hit All time high at $10.9 million, please come to check our project and let's DMTC get list on Coingecko to let's everyone in this whole world know DMTC.

DIAMOND The Cat Coin

Diamond The Cat Coin ($DMTC.X) is gaining attention as traders discuss its potential for a significant breakout, fueled by strong buying activity and a build-up of energy on the charts. Community members highlight positive chart signals and increasing volume, suggesting a possible surge. The coin is being touted as a hidden gem with momentum, with many anticipating substantial gains.

Pump.fun

$PUMP.X is trending as the community rallies around its potential as a leading platform for meme coin creation on the Solana blockchain, with discussions focusing on its buyback mechanisms and upcoming catalysts. Some traders are speculating on near-term price targets, while others emphasize the long-term vision and community-driven growth.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X is trending as the community rallies around this Solana-based meme coin, emphasizing its commitment to donating to animal shelters. Community members are actively discussing its potential for growth and comparing it to other meme coins like $DOGE.X and $SHIB.X, while also spreading awareness with the recurring joke, 'What's Updog?'

Capital One Financial Corp. is a financial holding company, which engages in the provision of financial products and services. It operates through the following segments: Credit Card, Consumer Banking, and Commercial Banking. The Credit Card segment includes domestic consumer and small business card lending, and international card lending businesses. The Consumer Banking segment consists of branch-based lending and deposit gathering activities for consumers and small businesses. The Commercial Banking segment includes lending, deposit gathering and treasury management services to commercial real estate and commercial and industrial customers. The company was founded by Richard D. Fairbank on July 21, 1994 and is headquartered in McLean, VA.

Capital One Financial Corp.

Capital One ($COF) is trending amid discussions around its potential Discover merger and a lawsuit against the FDIC. The community is weighing the potential benefits of the Discover acquisition, such as increased market share and synergies, against concerns including regulatory hurdles and integration challenges. Some investors view the stock favorably with upcoming rate cuts, while others express concern about the company's exposure to subprime lending.

aleph.im is a decentralized cloud storage, database and computing platform, that is compatible with blockchains and speaks their languages. It aims to be the infrastructure layer of the DeFI (decentralized finance) ecosystem.

Aleph.im

Aleph.im is trending as community members discuss its potential for a significant move, citing technical indicators like a newly formed monthly MACD curling upward and cup and handle formations. Traders are expressing the need for patience while waiting for optimal buying opportunities and a potential setup for a pump. The conversation includes mentions of its undervalued status and comparison to other altcoins.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

Fair Isaac Corp. is trending as investors digest a mix of factors, including strong revenue growth, a significant stock buyback program, and insider selling by the CEO. Community discussion revolves around regulatory pressures from the potential adoption of rival scoring systems and whether the company's valuation remains justified amid these challenges. The stock's high valuation relative to peers and the broader economic context are also key points of debate.

Agnico Eagle Mines Ltd. engages in the exploration and production of gold. It operates through the following segments: Northern Business, Southern Business, and Exploration. The Northern Business segment comprises of LaRonde mine, LaRonde Zone 5 mine, Lapa mine, Goldex mine, Meadowbank mine including the Amaruq deposit, Canadian Malartic joint operation, Meliadine project and Kittila mine. The Southern Business segment consists of Pinos Altos mine, Creston Mascota mine, and La India mine. The Exploration segment represents the exploration offices in the United States, Europe, Canada, and Latin America. The company was founded by Paul Penna in 1957 and is headquartered in Toronto, Canada.

Agnico Eagle Mines Ltd

Agnico Eagle Mines is trending due to strategic capital redeployment, including selling its stake in Orla Mining and increasing its investment in Maple Gold, moves that have sparked debate about future growth. Community discussions revolve around the implications of these decisions for investors and whether the company's premium valuation is justified. The stock's performance is being assessed in the context of rising gold prices and the company's strong earnings.

Why Queen Kitty ($QKitty) Is The Meme Token You’ve Been Waiting For  Queen Kitty isn’t just another hype project—this is a real movement with substance and community power!  Why hold $QKitty? 😼 Real dev, real builds: No fake teams, no copy-paste code. Everything you see is made from scratch. 💧 Working Faucet: Free QKitty for the community. Want to know how? Just ask! 🏆 Big Buy Competition Bot: See top buyers live, fight for the throne, and win rewards! 🎮 Multi-token P2E game coming soon: Play and earn across Web, iOS, Android! 🐾 NFT collecting soon: Cutest collection in crypto, bringing perks and more ways to earn.  Queen Kitty means innovation, transparency, and real delivery for holders. Curious? Join the chat and ask anything!  $QKitty: By the community, for the community. To the moon, together! 🚀🐱

Queen Kitty

Queen Kitty ($QKITTY.X) is trending as the community celebrates a recent airdrop in collaboration with $BROKE.X. The airdrop seems to be the main catalyst, with many users expressing excitement and discussing potential price breakouts based on technical indicators. Community members highlight the ongoing development and potential of this token on the Solana network.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects

Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.

BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?

Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig, showing high response rates and manageable safety.

Merck (MRK) Outpaces Stock Market Gains: What You Should Know

Merck (MRK) concluded the recent trading session at $85.11, signifying a +1.28% move from its prior day's close.

Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?

Merck stock is down 14% this year as Keytruda-led growth gets offset by Gardasil weakness and looming patent risks, which cloud the outlook.

Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? 

Bristol Myers struggles with falling shares and legacy drug headwinds, but growth drugs and new approvals help steady revenues.

U.S. stocks closed Wednesday’s session mixed, with the broader S&amp;P 500 Index and the Nasdaq Composite hitting fresh highs, while the Dow Jones Industrial Average retreated.Although the tame producer price inflation report generated some strength in the market in the morning session, the perils of trading an overbought market made traders cautious as the session progressed.The following stocks saw the biggest volume surge in extended trading, even as the market turns its attention to the August consumer price inflation CPI) report due on Thursday:SLB Ltd. (SLB)After-hours move: 0.14%Trading volume: 5.86 millionOilfield services company SLB remained on investors’ radar despite the lack of any significant news. The Houston, Texas-based company’s shares rose over 1% on Wednesday, outperforming the broader market, after crude oil futures climbed 1.7% during the session.&nbsp;The stock, however, is down 3.5% for the year-to-date period.<figure class="image"><img style="aspect-ratio:618/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_40_24_AM_png_ff671b9818.webp" alt="Screenshot 2025-09-11 at 12.40.24 AM.png" width="618" height="54"><figcaption>SLB sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/SLB">SLB stock</a> remained ‘neutral’ (51/100) by late Wednesday, and the message volume also stayed ‘normal.’Apple, Inc. (APPL)After-hours move: +0.10%Trading volume: 4.67 millionApple’s stock tumbled over 3% on Wednesday, even as the broader market managed to close in the green. The drop came despite the stock snagging a slew of price target hikes from Wall Street firms following the “Awe Dropping” hardware launch event held on Tuesday.BofA, Rosenblatt, Melius Research and Evercore ISI were among the firms that upped their price targets for Apple’s stock, with the updated estimates from these firms ranging from $241 to $290, the Fly reported. JPMorgan and Citi said the launch event was aligned with their expectations, while Morgan Stanley said it was slightly more awe-dropping than expectations.<a href="https://stocktwits.com/symbol/AAPL">Apple stock</a> is down about 9.1% year-to-date (YTD).<figure class="image"><img style="aspect-ratio:615/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_42_11_AM_png_38eba34d1f.webp" alt="Screenshot 2025-09-11 at 12.42.11 AM.png" width="615" height="58"><figcaption>AAPL sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>Retail sentiment toward the stock remained ‘extremely bullish’ (85/100), and the message volume was ‘extremely high.’&nbsp;Nvidia Corp. (NVDA)After-hours move: -0.10%Trading volume: 4.21 millionNvidia rode on the back of Oracle's (ORCL) exuberance and ended Wednesday’s session up nearly 5% at $177.33, although it was off its all-time intraday high of $184.48. However, retail interest is on the wane. On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/NVDA">Nvidia stock</a> remained ‘bearish’ (37/100). The message volume on the stream was ‘low’ relative to historical norms.<figure class="image"><img style="aspect-ratio:622/59;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_43_57_AM_png_ec461b54d9.webp" alt="Screenshot 2025-09-11 at 12.43.57 AM.png" width="622" height="59"><figcaption>NVDA sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>The shares of the artificial intelligence chipmaker are up more than 32% this year.Merck &amp; Co. (MRK)After-hours move: +0.10%Trading volume: 3.91 millionPharma giant Merck has come onto investors’ radar as it declined on Wednesday, aligning with the pullback in the healthcare stocks in the afternoon. The S&amp;P 500 Healthcare Index fell 0.91% on Wednesday.The company also abandoned plans to build a research center in the U.K., citing the “challenges of the UK not making meaningful progress towards addressing the lack of investment in the life science industry and the overall undervaluation of innovative medicines and vaccines by successive UK governments,” the London Times&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.thetimes.com/business-money/companies/article/merck-attacks-uk-life-sciences-investment-scraps-1bn-hq-jbzz9nmnb">reported.</a><figure class="image"><img style="aspect-ratio:620/50;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_45_04_AM_png_6aeae81193.webp" alt="Screenshot 2025-09-11 at 12.45.04 AM.png" width="620" height="50"><figcaption>MRK sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/MRK">Merck stock</a>, which has fallen nearly 14% this year, elicited ‘bearish’ sentiment (42/100) from among users on Stocktwits. The message volume was at ‘normal’ levels.Gilead Sciences, Inc. (GILD)After-hours move: +0.65%Trading volume: 3.57 millionGildead Sciences was in the news on Wednesday as RBC Capital Markets named the company as one of the beneficiaries of Health and Human Services (HHS) Secretary and prominent antivaxxer Robert Kennedy's potential departure from the agency.&nbsp;The firm said healthcare could be viewed as "less unpredictable" and "more investable" if the secretary were to depart his position, according to the Fly.Kennedy has been under pressure from HHS employees, both former and current, to quit, as they alleged that he has put the health of America at risk with his actions, which include cancelling emergency use authorizations for COVID-19 vaccines without providing data or methods to justify the decision.<figure class="image"><img style="aspect-ratio:616/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_46_18_AM_png_9b7d1d480e.webp" alt="Screenshot 2025-09-11 at 12.46.18 AM.png" width="616" height="53"><figcaption>GILD sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/GILD">Gilead Sciences stock</a> remained ‘neutral’ (47/100). and the message volume also stayed at ‘normal’ levels.The stock has gained 26.5% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/goldman-sachs-ceo-sees-25-bps-fed-rate-cut-as-done-deal/chwN5NiRdH4">Will Fed Cut Rates Next Week? What Goldman Sachs CEO David Solomon Predicts For September Meeting And Rest Of 2025</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on July 30, 2025, in New York City. 

SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Two stocks, each from the tech and healthcare sectors, experienced brisk trading activity in the post-market session on Wednesday, although volumes were relatively muted.

Equity

Two stocks, each from the tech and healthcare sectors, experienced brisk trading activity in the post-market session on Wednesday, although volumes were relatively muted.


Merck (MRK) has reportedly scrapped a £1 billion ($1.35 billion) London research centre and intends to lay off over 100 scientific staff in the U.K.The Financial Times <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/5ace49a8-47ab-409d-8909-6edb107ce71a">reported </a>on Wednesday that the drugmaker scrapped the research centre in King’s Cross, which was due to open in 2027, and instead would move research activity to existing sites, predominantly in the U.S. The company committed to the research centre focused on neuroscience, inflammation, and immunology in King’s Cross in 2017, and construction commenced in 2023, FT said.Merck would also lay off 125 scientists and support staff who had been working on early discovery efforts at the Francis Crick Institute and the London Bioscience Innovation Centre, according to the report.However, the company will continue to run clinical trials in the country and will have about 1,600 staff working on these development programs and other areas, the report said. Merck told FT in a statement that the U.K. is “not internationally competitive.”The decision comes on the heels of a battle between drug makers and the U.K. Health Secretary Wes Streeting on medicine prices. However, Merck told FT that its decision to scrap the London research centre was not related to the drug-pricing negotiations with the government.The company, however, stated that the U.K. would lag behind its European peers in the share of the health budget allocated to drugs unless it improved its ability to attract and retain investment, according to the FT.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MRK">MRK stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:625/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_10_at_12_15_49_PM_png_73cef3623f.webp" alt="MRK's Sentiment Meter and Message Volume as of 12:16 p.m. ET on Sept. 10, 2025 | Source: Stocktwits" width="625" height="62"><figcaption>MRK's Sentiment Meter and Message Volume as of 12:16 p.m. ET on Sept. 10, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expects the stock to reach $97.50, implying a reasonable upside from its current trading levels.<stembedurl>https://stocktwits.com/wilpd/message/628089752</stembedurl>Meanwhile, in the United States, Merck <a href="https://stocktwits.com/news-articles/markets/equity/trump-to-issue-60-day-warning-letters-to-drugmakers-over-pricing/choL0IMRdGB">faces</a> a September-end deadline to reduce the cost of its medicines as Trump pushes drugmakers to lower the cost of drugs in the U.S. to the levels paid by other developed nations.According to data from Koyfin, 15 of the 37 analysts covering Merck rate it ‘Buy’ or higher, while 12 rate it ‘Hold’. The average price target for the stock is $102.33, representing an upside of over 22%.MRK stock is down by 16% this year and by 27% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wells-fargo-analyst-expects-tesla-q3-deliveries-to-fall-below-consensus-estimate/chwkig8RduAhttps://stocktwits.com/news-articles/markets/equity/wells-fargo-analyst-expects-tesla-q3-deliveries-to-fall-below-consensus-estimate/chwkig8RduA">This Analyst Expects Tesla Q3 Deliveries To Fall Below Consensus Estimates: Retail Sees Rally To $400 After Next Earnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50 

The Financial Times reported on Wednesday that the drugmaker scrapped the research centre in King’s Cross, which was due to open in 2027, and will instead move research activity to existing sites. 

J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum

J&J secures FDA approval for Inlexzoh, which boosts its Innovative Medicine pipeline and reinforces long-term growth momentum.

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study

Summit Therapeutics plunges 25% after its HARMONi study shows sharp regional differences in lung cancer trial outcomes.

Will LLY's Oncology Portfolio Provide Key Diversification Benefits?

Eli Lilly's oncology portfolio, led by Verzenio and Jaypirca, is adding diversification to its cardiometabolic-driven growth story.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

MRK
Merck & Co Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MRK News

MRK Merck & Co Inc